论文部分内容阅读
目的:探究原发性高血压患者应用缬沙坦与吲达帕胺联合治疗的效果。方法:选取我院2014年2月~2015年2月收治的原发性高血压患者80例作为研究对象,随机分为2组,对照组施以缬沙坦治疗,观察组在对照组的基础上联合吲达帕胺,对比分析两组患者治疗效果。结果:对比分析两组患者治疗效果,观察组明显优于对照组,两组差异显著,存在统计学意义(P<0.05)。结论:治疗原发性高血压时应用缬沙坦与吲达帕胺联合治疗,有利于提升治疗效果,控制患者血压,具有较大临床推广价值。
Objective: To investigate the effect of combined valsartan and indapamide in patients with essential hypertension. Methods: Eighty patients with essential hypertension treated in our hospital from February 2014 to February 2015 were selected as study subjects and randomly divided into two groups. The control group was treated with valsartan. The observation group was basal in the control group On the combination of indapamide, comparative analysis of two groups of patients treatment. Results: The curative effect of two groups of patients was comparatively analyzed. The observation group was obviously superior to the control group. There was significant difference between the two groups (P <0.05). Conclusion: The combination of valsartan and indapamide in the treatment of essential hypertension is beneficial to improve the therapeutic effect and control the blood pressure of patients with great clinical value.